| Ytd | 89.77% | |
| 1y | 85.73% |
| Open | 14.84 | Prev Close | 14.84 | Low | 14.84 | High | 14.84 | Mkt Cap | 2.20B |
| Vol | 38.51M | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -5.17 |
| Beta | 1.26 | Short Ratio | 0.74 | Inst. Own | 103.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 30.38 |
ETNB News
The market continues to trade deeper in overbought territory based on most traditional valuation met
Obesity, type 2 diabetes, and cancer continue to grow across the globe, but pharma stocks remain off
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
NEW YORK , Sept. 23, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde &
There has been some speculation on Seeking Alpha recently on several biotech/biopharma names that ma
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
The "Jimmy Kimmel Live" drama coincided with reports of tit-for-tat maneuvering between the
Small-cap benchmark Russell 2000 ETF hits record high after Fed cuts rates, hinting at more cuts. Sm
On Thursday, Roche Holdings AG RHHBY agreed to acquire 89bio, Inc. ETNB for $2.4 billion. 89Bio is a
U.S. stock futures advanced on Thursday following Wednesday's mixed moves. Futures of major benc
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t
Roche has agreed to acquire American biotech 89bio in a transaction worth up to $3.5 billion, as it
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating 89bio (Nasdaq: ETNB) for possible breach
The deal seeks to strengthen the drugmaker's pipeline by adding an experimental drug for an obesity
Roche said on Thursday it agreed to acquire U.S. biotech firm 89bio ETNB.O for up to $3.5 billion to
– 89bio stockholders to receive up to $20.50 per share in cash, comprised of $14.50 per share in cas
89bio, Inc. (NASDAQ:ETNB ) Cantor Global Healthcare Conference 2025 September 4, 2025 11:30 AM EDT C
SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ET
89bio, Inc. (NASDAQ:ETNB ) Citi's Biopharma Back to School Conference September 3, 2025 11:15 AM EDT
Pegozafermin is ETNB's long-acting FGF21 analog. It's undergoing three Phase 3 trials. Two of those
89bio (ETNB) Q2 R&D Jumps 131%
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the
Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday.
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Tuesday. Here are some bi
Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead en
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some b
HC Wainwright & Co. cut the price target for 89bio, Inc. (NASDAQ: ETNB) from $27 to $25. HC
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the co
Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tues
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q
Tuesday's session saw 211 companies set new 52-week lows.
On Friday, 213 companies hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Wednesday's session saw 784 companies set new 52-week lows.
On Thursday, 236 companies hit new 52-week lows.
On Monday, 466 companies hit new 52-week lows.
During Friday's morning session, 234 stocks hit new 52-week lows.